Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mark Tullman"'
Autor:
Brenda Jenkins, Emmanuel Chartier-Kastler, Benjamin M. Brucker, Meryl Mandle, Alfred Kohan, Veronique Keppenne, Mark Tullman, Pierre Denys, Blair Egerdie, Jean Paul Nicandro
Publikováno v:
Neurology
ObjectiveTo evaluate the efficacy and safety of onabotulinumtoxinA 100 U in noncatheterizing patients with multiple sclerosis (MS) with urinary incontinence (UI) due to neurogenic detrusor overactivity (NDO).MethodsIn this randomized, double-blind ph
Autor:
Mark Tullman
Publikováno v:
CONTINUUM: Lifelong Learning in Neurology. 10:142-172
Most patients with multiple sclerosis (MS) experience symptoms that are disabling and/or socially distressing on a daily basis. In addition to the disease-modifying agents that can alter the course of MS, symptomatic therapies play an integral part i
Autor:
George H. Kraft, Dagmar Amtmann, Adrian L. Rabinowicz, Susan E. Bennett, Mark Tullman, Marcia Finlayson, Matthew F Sidovar, Matthew Sutliff
Publikováno v:
Postgraduate medicine. 126(5)
Upper extremity (UE) dysfunction may be present in up to ~80% of individuals with multiple sclerosis (MS), although its importance may be under-recognized relative to walking impairment, which is the hallmark symptom of MS. Upper extremity dysfunctio
Autor:
Luanne M. Metz, Jai Perumal, Corey C. Ford, Kenneth P. Johnson, Mark Tullman, R. P. Lisak, Alexandros Tselis, Omar Khan, Massimo Filippi
The past decade has witnessed a revolution in the treatment of multiple sclerosis (MS), the most common demyelinating disorder of the human CNS. After being considered as an untreatable disease for more than a century, six disease-modifying treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bba2e7a239aa7046a37a7ce274e2967